Address: Rua Giacomo Chiesi, 151, km 39,2 Estrada dos Romeiros Santana de Parnaíba – SP CEP: 06500-970,Brazil
Tel: 11 4622-8500
Web: http://www.chiesi.com.br/
The Chiesi Group, an ethical pharmaceutical company, with more than 75 years dedicated to research and development of new medicines and technologies, is today one of the leading pharmaceutical companies in Europe, with an extensive line of products in various therapeutic segments.
Based in Parma, Italy, the group operates in all continents with 22 direct branches, three production plants (Italy, France and Brazil) and four research and development centers for new products and technologies (Italy, France, USA and England).
The Chiesi Brazil subsidiary has been responsible for operations in Brazil since 1976, offering healthcare professionals and patients, drugs with the quality and reliability are recognized around the world.
Chiesi Brazil provides important resources for the drug therapy of diseases related to various specialties such as respiratory diseases (asthma and chronic obstructive pulmonary disease), allergic diseases (rhinitis and urticaria), cardiovascular (hypertension and angina), metabolic disorders (dyslipidemia), muscle skeletal Poliaminoacids and supplements.
In addition Chiesi Brazil develops technologies that make life easier for patients, such as inhalers and spacers for the administration of drugs used by inhalation. In this area, the Chiesi Group has developed a new technology called Modulite ®, making medicinal aerosols which are free of substances harmful to the ozone layer, and consequently, environment friendly.
Chiesi Brazil has also developed the use of tobramycin for inhalation, used for the treatment of lung infections present in patients with cystic fibrosis.
Modulite, respiratory diseases (asthma and chronic obstructive pulmonary disease), allergic diseases (rhinitis and urticaria), cardiovascular (hypertension and angina), metabolic disorders (dyslipidemia), musculo-skeletal, Poliaminoacids and supplements.
Yesterday, Minister Pimentel unveiled the Brazil Maior plan to increase competitiveness and growth across a variety of industrial sectors. If you had to give recommendations to improve the Brazilian pharmaceutical…
Paulo Vitor de Andrade, founder and director of Grupo Polar, elaborates on his journey to build the Brazilian company of reference in cold chain solutions and the company’s relentless efforts…
Poul Sorensen, director of Geistlich Pharma in Brazil, details the importance of educational activities for Geistlich’s business, the affiliate’s desire to bring new segments of Geistlich’s portfolio to Brazil and…
Jun Eguti, general manager of Grünenthal Brazil, highlights the global transformation Grünenthal has undergone in the past two years, the huge potential the Brazilian affiliate has to become one of…
Alexei Kolchin, general manager of GSK Brazil, discusses adapting to Brazil, having previously held the equivalent role in Russia, the Brazilian affiliate’s contribution to GSK’s global growth, and its embrace…
Roberto Godoy, GM of Guerbet Brazil and marketing director of Guerbet Latin America, a leading French-based contrast media company present in Brazil for the past 40 years, explains his role…
Paulo Henrique Fraccaro, superintendent of the Brazilian Medical and Dental Devices Manufacturers Association (ABIMO), describes the central role of the association within the Brazilian medtech industry, the phenomenal potential of…
Fernando Silveira F°, country manager in Brazil of ISDIN, documents the successful market entry and rapid development of this dermatology focused company in Brazil, while ISDIN has managed to establish…
Luis Fernando Lenski, head of South Cone and general manager of Galderma Brazil, provides insights into the affiliate’s heightened and tireless efforts in terms of medical education and his focus…
Juan Pablo Udry, general manager Brazil and Latin America at Boiron, the world’s undisputed leader in homeopathic medicines, provides an insightful overview of the Brazilian and Latin American landscape for…
Cesar Rengifo, senior vice president and area director Emerging Markets West at GSK, the fastest growing multinational company in both Brazil and Latin America, discusses the perfect match between GSK’s…
Ivo Mafra, president and founder of DC Logistics Brazil, a Brazilian based third party logistics (3PL) company awarded Best partner Worldwide and Latin America 2016 – WCA world, details the…
Alex Carvalho, general manager Pierre Fabre Brazil, provides insights into the rapidly ascending trajectory of the company in Brazil, its utmost commitment to oncology in the country, and Pierre Fabre’s…
See our Cookie Privacy Policy Here
